Shanghai RAAS Blood Products Hits Day Low of CNY 6.00 Amid Price Pressure

Shanghai RAAS Blood Products Co., Ltd. experienced a notable decline today, with the stock dropping by 3.06% and reaching an intraday low of CNY 6.00. This performance stands in contrast to the China Shanghai Composite, which fell by 1.24% on the same day. Over the past week, the stock has decreased by 3.99%, while its monthly performance shows a decline of 3.53%. In terms of longer-term performance, Shanghai RAAS has faced challenges, with a significant drop of 14.85% over the past year, compared to a 16.08% increase in the China Shanghai Composite. Year-to-date, the stock is down 5.05%, and over the last five years, it has declined by 22.22%, while the broader index has gained 16.22%. Key financial metrics indicate that the company has struggled with growth, as evidenced by a net profit decline of 19.97% over the past nine months and a return on equity of just 5.60%. The market capitalization stands at CNY 42,046 million, with a price-to-earnings ratio of 22.00 and a dividend yield of 0.77%.